Percutaneous transhepatic thrombectomy and pharmacologic thrombolysis of mesenteric venous thrombosis.
Mesenteric venous occlusion is a rare yet highly morbid condition that is traditionally treated with anticoagulation while surgery serves as the last resort. Percutaneous intervention provides an effective option with relatively low mortality and morbidity. We herein describe use of transhepatic percutaneous thrombectomy and pharmacologic thrombolysis in treating two cases of symptomatic mesenteric venous thrombosis. These cases underscore the fact that transhepatic thrombectomy and thrombolysis are a highly effective strategy for treating acute symptomatic mesenteric venous thrombosis. Several percutaneous techniques are also reviewed.
Zhou
Wei
W
Division of Vascular Surgery and Endovascular Therapy, Michael E. DeBakey Department of Surgery, VA Medical Center, Baylor College of Medicine, 1709 Dryden Street, Houston, TX 77030, USA. wzhou1@bcm.edu
Choi
Lorraine
L
Lin
Peter H
PH
Dardik
Alan
A
Eraso
Andrea
A
Lumsden
Alan B
AB
D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage; D006801:Humans; D007263:Infusions, Parenteral / Q000379:methods; D008297:Male; D008641:Mesenteric Vascular Occlusion / Q000209:etiology / Q000628:therapy; D008642:Mesenteric Veins / Q000000981:diagnostic imaging / Q000601:surgery*; D008875:Middle Aged; D011169:Portal Vein / Q000000981:diagnostic imaging / Q000601:surgery; D017131:Thrombectomy / Q000379:methods*; D015912:Thrombolytic Therapy / Q000379:methods*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage; D014057:Tomography, X-Ray Computed / Q000379:methods; D016896:Treatment Outcome; D020246:Venous Thrombosis / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator